Related references
Note: Only part of the references are listed.Low-Dose Total Body Irradiation and Fludarabine Conditioning for HLA Class I-Mismatched Donor Stem Cell Transplantation and Immunologic Recovery in Patients with Hematologic Malignancies: A Multicenter Trial
Hirohisa Nakamae et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2010)
HLA-Mismatched Unrelated Donors as an Alternative Graft Source for Allogeneic Stem Cell Transplantation after Antithymocyte Globulin-Containing Conditioning Regimen
Nicolaus Kroeger et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2009)
Full-intensity and reduced-intensity allogeneic stem cell transplantation in AML
C. F. Craddock
BONE MARROW TRANSPLANTATION (2008)
Allogeneic transplantation for ALL in adults
A. Stein et al.
BONE MARROW TRANSPLANTATION (2008)
Hematopoietic cell transplantation for correction of primary immunodeficiencies
A. H. Filipovich
BONE MARROW TRANSPLANTATION (2008)
Risk factors for acute graft-versus-host disease grades II-IV after reduced intensity conditioning allogeneic stem cell transplantation with unrelated donors -: a single centre study
M. Remberger et al.
BONE MARROW TRANSPLANTATION (2008)
Current status of reduced-intensity allogeneic stem cell transplantation using alternative donors
Y-B Chen et al.
LEUKEMIA (2008)
Eleven million donors in Bone Marrow Donors Worldwide! Time for reassessment?
J. J. van Rood et al.
BONE MARROW TRANSPLANTATION (2008)
High-resolution donor-recipient HLA matching contributes to the success of unrelated donor marrow transplantation
Stephanie J. Lee et al.
BLOOD (2007)
High-risk HLA allele mismatch combinations responsible for severe acute graft-versus-host disease and implication for its molecular mechanism
Takakazu Kawase et al.
BLOOD (2007)
Relapse risk in patients with malignant diseases given allogeneic hematopoietic cell transplantation after nonmyeloablative conditioning
Christoph Kahl et al.
BLOOD (2007)
Chronic graft-versus-host disease after allogeneic bone marrow transplantation from an unrelated donor:: incidence, risk factors and association with relapse.: A report from the Japan Marrow Donor Program
Shinichi Ozawa et al.
BRITISH JOURNAL OF HAEMATOLOGY (2007)
Outcomes of alemtuzumab-based reduced intensity conditioning stem cell transplantation using unrelated donors for myelodysplastic syndromes
Zi Yi Lim et al.
BRITISH JOURNAL OF HAEMATOLOGY (2006)
HLA-C mismatch is associated with inferior survival after unrelated donor non-myeloablative hematopoietic stem cell transplantation
VT Ho et al.
BONE MARROW TRANSPLANTATION (2006)
Hematopoietic stem cell donor selection: the Europdonor experience
M. Ouldshoorn et al.
HUMAN IMMUNOLOGY (2006)
Impact of human leucocyte antigen mismatch on graft-versus-host disease and graft failure after reduced intensity conditioning allogeneic haematopoietic stem cell transplantation from related donors
T Teshima et al.
BRITISH JOURNAL OF HAEMATOLOGY (2005)
Role of allogeneic stem cell transplantation in multiple myeloma
KJ Thomson et al.
EXPERT REVIEW OF ANTICANCER THERAPY (2005)
Reduced intensity allogeneic stem cell transplantation for low grade non-Hodgkin's lymphoma
EC Morris et al.
BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY (2005)
Limits of HLA mismatching in unrelated hematopoietic cell transplantation
EW Petersdorf et al.
BLOOD (2004)
HLA matching in allogeneic stem cell transplantation
EW Petersdorf
CURRENT OPINION IN HEMATOLOGY (2004)
The clinical significance of human leukocyte antigen (HLA) allele compatibility in patients receiving a marrow transplant from serologically HLA-A, HLA-B, and HLA-DR matched unrelated donors
Y Morishima et al.
BLOOD (2002)
Limiting transplantation-related mortality following unrelated donor stem cell transplantation by using a nonmyeloablative conditioning regimen
R Chakraverty et al.
BLOOD (2002)
Major-histocompatibility-complex class I alleles and antigens in hematopoietic-cell transplantation.
EW Petersdorf et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
Share Paper
